Bilde av Kirsebom, Bjørn-Eivind
Bilde av Kirsebom, Bjørn-Eivind
Behavioral Neuroscience, Aging and Dementia bjorn-eivind.s.kirsebom@uit.no

Bjørn-Eivind Kirsebom


Associate professor II

Job description

Conducting research, lecturing and supervision of doctoral candiates in clinical neuropsychology/neurology with emphasis on neurodegenerative diseases in old age (Primarily Alzheimer's Disease). 
PI Dementia Disease Initiation (DDI) Tromsø. 


  • Fernando Gonzalez-Ortiz, Bjørn-Eivind Seljelid Kirsebom, José Contador, Jordan E. Tanley, Per Selnes, Berglind Gísladóttir et al.:
    Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
    Nature Communications 2024 DOI
  • Stephanie Knudtzon, Kaja Nordengen, Gøril Rolfseng Grøntvedt, Jonas Alexander Jarholm, Ingvild Vøllo Eliassen, Per Selnes et al.:
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease
    Neurobiology of Aging 2024 DOI
  • Mostafa Mehdipour Ghazi, Per Selnes, Santiago Timón-Reina, Sandra Tecelão, Silvia Ingala, Atle Bjørnerud et al.:
    Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts
    Frontiers in Aging Neuroscience 2024 DOI
  • Stephanie Knudtzon, Kaja Nordengen, Gøril Rolfseng Grøntvedt, Jonas Alexander Jarholm, Ingvild Vøllo Eliassen, Per Selnes et al.:
    Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s Disease
    Neurobiology of Aging 2024
  • Ingrid Myrvoll Lorentzen, Johan Jacob Espenes, Ingvild Vøllo Eliassen, Erik Hessen, Knut K Waterloo, Arne Exner Nakling et al.:
    Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer’s disease
    Applied neuropsychology: Adult 2023 ARKIV / DOI
  • Fredrik Öhman, Marie Eckerström, Erik Hessen, Johan Jacob Espenes, Ingvild Vøllo Eliassen, Ingrid Myrvoll Lorentzen et al.:
    Demographically adjusted Rey–Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49–77 years and comparison with North American norms
    Scandinavian Journal of Psychology 2023 ARKIV / DOI
  • Klaus Thanke Aspli, Jan Aaseth, Trygve Holmøy, Kaj Blennow, Henrik Zetterberg, Bjørn-Eivind Seljelid Kirsebom et al.:
    CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
    Brain Sciences 2023 ARKIV / FULLTEKST / DOI
  • Mathilde Suhr Hemminghyth, Luiza Chwiszczuk, Monica Haraldseid Breitve, Berglind Gisladottir, Gøril Rolfseng Grøntvedt, Arne Exner Nakling et al.:
    Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults
    Neurobiology of Aging 2023 ARKIV / DOI
  • Therese Händel Waggestad, Bjørn-Eivind Kirsebom, Carsten Strobel, Anders Wallin, Marie Eckerström, Tormod Fladby et al.:
    Improving validity of the trail making test with alphabet support
    Frontiers in Psychology 2023 ARKIV / DOI
  • Kaja Nordengen, Bjørn-Eivind Seljelid Kirsebom, Grit Richter, Lene Pålhaugen, Berglind Gisladottir, Nikias Ioannis Siafarikas et al.:
    Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
    Journal of Neuroinflammation 2023 ARKIV / DOI
  • Santiago Timón, Mariano Rincón, Rafael Martínez-Tomás, Bjørn-Eivind Seljelid Kirsebom, Tormod Fladby :
    A Knowledge Graph Framework for Dementia Research Data
    Applied Sciences 2023 ARKIV / DOI
  • Johan Jacob Espenes, Ingrid Myrvoll Lorentzen, Ingvild Vøllo Eliassen, Erik Hessen, Knut K Waterloo, Santiago Timón et al.:
    Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20–85
    The Clinical Neuropsychologist 2023 ARKIV / DOI
  • Jonas Alexander Jarholm, Atle Bjørnerud, Turi Olene Dalaker, Mehdi Sadat Akhavi, Bjørn-Eivind Kirsebom, Lene Pålhaugen et al.:
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort
    Journal of Alzheimer's Disease 2023 ARKIV / DOI
  • Miguel Germán Borda, Daniel Ferreira, Per Selnes, Diego Alejandro Tovar-Rios, Alberto Jaramillo-Jiménez, Bjørn-Eivind Kirsebom et al.:
    Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness
    Dementia and Geriatric Cognitive Disorders 2022 ARKIV / DOI
  • Jacob Espenes, Ingvild Vøllo Eliassen, Fredrik Öhman, Erik Hessen, Knut K Waterloo, Marie Eckerström et al.:
    Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49–79 and comparison with published norms
    The Clinical Neuropsychologist 2022 ARKIV / DOI
  • Bjørn-Eivind Kirsebom, Grit Richter, Kaja Nordengen, Dag Aarsland, Geir Bråthen, Betty M Tijms et al.:
    Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
    Brain Communications 2022 ARKIV / DOI
  • Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Tormod Fladby, Knut Waterloo, Sigrid Botne Sando, Mathilde Suhr Hemminghyth et al.:
    Regression-Based Cognitive Change Norms Applied in Biochemically Defined Predementia Alzheimer’s Disease
    Neuropsychology 2022 ARKIV / DOI
  • Ingrid Myrvoll Lorentzen, Johan Jacob Espenes, Erik Hessen, Knut Waterloo, Geir Bråthen, Santiago Timón et al.:
    Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample
    Applied neuropsychology: Adult 2021 ARKIV / DOI
  • Nikias Ioannis Siafarikas, Bjørn-Eivind Kirsebom, Deepak P Srivastava, Cecilia Magdalena Eriksson, Eirik Auning, Erik Hessen et al.:
    Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
    Scientific Reports 2021 ARKIV / DOI
  • Anne Katrine Bergland, Petroula Proitsi, Bjørn-Eivind Kirsebom, Hogne Sønnesyn, Abdul Hye, Alf Inge Larsen et al.:
    Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease
    Journal of Alzheimer's Disease 2020 DOI
  • Ragna Espenes, Bjørn-Eivind Kirsebom, Cecilia Magdalena Eriksson, Knut K Waterloo, Erik Hessen, Stein Harald Johnsen et al.:
    Amyloid plaques and symptoms of depression links to medical help-seeking due to subjective cognitive decline
    Journal of Alzheimer's Disease 2020 ARKIV / DOI
  • Johan Jacob Espenes, Erik Hessen, Ingvild Vøllo Eliassen, Knut Waterloo, Marie Eckerström, Sigrid Botne Sando et al.:
    Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years
    The Clinical Neuropsychologist 2020 ARKIV / DOI
  • Ingvild Vøllo Eliassen, Tormod Fladby, Bjørn-Eivind Kirsebom, Knut Waterloo, Marie Eckerström, Anders Wallin et al.:
    Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia
    Neuropsychology 2020 ARKIV / DOI
  • Kaja Nordengen, Bjørn-Eivind Kirsebom, Kristi Henjum, Per Selnes, Berglind Gisladottir, Marianne Wettergreen et al.:
    Glial activation and inflammation along the Alzheimer's disease continuum
    Journal of Neuroinflammation 2019 ARKIV / DOI
  • Bjørn-Eivind Kirsebom, Ragna Espenes, Erik Hessen, Knut Waterloo, Stein Harald Johnsen, Elisabeth Gundersen et al.:
    Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
    The Clinical Neuropsychologist 2019 ARKIV / DOI
  • Erik Hessen, Bjørn-Eivind Kirsebom, Cecilia Magdalena Eriksson, Carl Fredrik Andestad Eliassen, Arne Nakling, Geir Bråthen et al.:
    In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
    Journal of Alzheimer's Disease 2019 ARKIV / DOI
  • Bjørn-Eivind Kirsebom, Kaja Nordengen, Per Selnes, Knut Waterloo, Silje Bøen Torsetnes, Berglind Gisladottir et al.:
    Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
    Alzheimer's and Dementia: Translational Research and Clinical Interventions 10. November 2018 ARKIV / DOI
  • Bjørn-Eivind Seljelid Bordewic Kirsebom, Ragna Espenes, Knut Waterloo, Erik Hessen, Stein Harald Johnsen, Geir Bråthen et al.:
    Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
    Journal of Alzheimer's Disease 2017 ARKIV / DOI
  • Tormod Fladby, Lene Pålhaugen, Per Selnes, Knut Waterloo, Geir Bråthen, Erik Hessen et al.:
    Detecting at-risk Alzheimer's disease cases
    Journal of Alzheimer's Disease 29. August 2017 DOI
  • Luiza Chwiszczuk, Monica Haraldseid Breitve, Bjørn-Eivind Kirsebom, Per Selnes, John Christian Jøraholmen Fløvig, Anne Brita Knapskog et al.:
    The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
    Frontiers in Aging Neuroscience 2023 ARKIV / DOI
  • Mathilde Suhr Hemminghyth, Monica Haraldseid Breitve, Berglind Gisladottir, Gøril Rolfseng Grøntvedt, Arne Exner Nakling, Tormod Fladby et al.:
    Cerebrospinal fluid neurofilament light chain mediates age-related decline in learning and memory in healthy adults
    2023
  • Nikias Ioannis Siafarikas, Bjørn-Eivind Kirsebom, Deepak P. Srivastava, Cecilia Magdalena Eriksson, Eirik Auning, Erik Hessen et al.:
    Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression (Scientific Reports, (2021), 11, 1, (20375), 10.1038/s41598-021-99794-9)
    Scientific Reports 2022 DOI
  • Bjørn-Eivind Kirsebom :
    Hva vet vi om Alzheimers sykdom i dag, og finnes det en kur?
    Nordlys 21. September 2020 DATA
  • Johan Jacob Espenes, Ingvild Vøllo Eliassen, Tormod Fladby, Marie Eckerström, Wallin Anders, Knut Waterloo et al.:
    Demographically adjusted test norms for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults from 41 to 79 years
    2020
  • Ragna Espenes, Bjørn-Eivind Kirsebom, Cecilia Magdalena Eriksson, Knut Waterloo, Stein Harald Johnsen, Erik Hessen et al.:
    Medical help-seeking in Subjective Cognitive Decline associated with lower CSF Aβ1-42 and reduced memory performance
    2019
  • Bjørn-Eivind Kirsebom :
    Vil avdekke Alzheimers sykdom så tidlig som mulig
    05. June 2019
  • Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Erik Hessen, Per Selnes, Knut Waterloo, Tormod Fladby :
    Distractor List Errors from Verbal Learning Test May Reveal Deficient Temporal Memory Encoding in Predementia Alzheimer’s Disease
    2019
  • Bjørn-Eivind Kirsebom :
    Tromsø-forskere jobber intenst med å løse alzheimer-gåten
    28. December 2019
  • Bjørn-Eivind Kirsebom :
    Frykter fordobling av demenstilfeller innen 2050: Tromsø-forskere undersøker om blåbær kan være kuren
    14. August 2019 DATA
  • Johan Jacob Espenes, Bjørn-Eivind Kirsebom, Ingvild Eliassen Vøllo, Ragna Espenes, Knut Waterloo, Erik Hessen et al.:
    Demographically adjusted norms for basic and derived measures on the Trail Making Test A & B based on a Norwegian sample age 40 – 84 years.
    2019
  • Bjørn-Eivind Kirsebom, Tine Viktoria Buberg :
    Forsker på demens: – Antioksidanter fra blåbær kan bidra til å bremse demens
    07. August 2019
  • Grit Richter, Bjørn-Eivind Kirsebom, Per Selnes, Kaja Nordengen, Knut Waterloo, Berglind Gisladottir et al.:
    An amyloid-coupled pre-dementia increased CSF neurogranin/BACE1 ratio may reflect early synapse affection in APOE-ɛ4 homozygotes
    2019
  • Bjørn-Eivind Kirsebom, Per Selnes, Grit Richter, Berglind Gisladottir, Marianne Wettergreen, Silje Bøen Torsetnes et al.:
    Cerebrospinal fluid Neurogranin/BACE1 ratio differentiate normal controls, pre-dementia Alzheimer’s and Parkinson’s disease cases.
    2019
  • Grit Richter, Bjørn-Eivind Kirsebom, Per Selnes, Kaja Nordengen, Knut Waterloo, Berglind Gisladottir et al.:
    Early increase in CSF neurogranin/BACE1 ratio in predementia APOE-ɛ4 homozygote cases with amyloid pathology
    2019
  • Bjørn-Eivind Kirsebom, Kaja Nordengen, Per Selnes, Knut Waterloo, Britta Brix, Eugeen Vanmechelen et al.:
    INCREASED CSF NEUROGRANIN/BACE1 RATIO IN AMYLOID POSITIVE SUBJECTS WITH SUBJECTIVE COGNITIVE DECLINE
    2018
  • Bjørn-Eivind Kirsebom, Ragna Espenes, Knut Waterloo, Stein Harald Johnsen, Tormod Fladby :
    Screening for Alzheimer's Disease: Cognitive Impairent in Self-Referred and Memory Clinic-Referred Patients
    2017

  • The 50 latest publications is shown on this page. See all publications in Cristin here →


    Research interests

    Clinical neuropsychology, regression-based norms, preclinical and prodromal Alzheimer's disease.